ARCHIVES

Amgen, J&J Defend ESA Indications.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

New Mexico Program Covers Entire State

January 21, 1977

Officials: Poisoning Unrelated to MD Anderson; Critics Allege Dysfunction in Handling of Affair

September 19, 2014

Nurses’ Work Environment Needs Change To Protect Patients From Errors, IOM Says

November 28, 2003

Senate Approves $47 Million For More AIDs Drugs

September 19, 1986

Obituaries: Eleanor Nealson, 59, NCI Liaison to Patients, Formed consumer Advisory Group

October 29, 1999

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987